Portfolio company
TileBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
TileBio develops artificial intelligence foundation models for digital pathology to assist clinicians and pharmaceutical companies with cancer diagnosis, biomarker discovery and drug development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Aignostics
Aignostics develops AI-powered digital pathology software and foundation models for biopharmaceutical companies, academic researchers and clinical laboratories to improve disease diagnosis and drug development.
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
ViewsML
This company develops an artificial intelligence platform providing virtual biomarker staining of pathology images for biopharmaceutical researchers, clinical trial teams and diagnostic laboratories.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Ibex
Ibex develops artificial intelligence software for cancer diagnostics to assist pathologists and laboratories with biopsy analysis and workflow efficiency.
Panakeia
The company develops artificial intelligence software to provide rapid molecular cancer biomarker analysis from tissue images for hospitals and pharmaceutical research organisations.
Ibex Medical
This company develops artificial intelligence software for cancer diagnostics to assist pathologists in labs and hospitals with biopsy analysis and quality control.
